🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Kentucky

Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Kentucky

5 pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa mga site sa Kentucky.

Mga Lungsod sa Kentucky

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • University of Kentucky/Markey Cancer Center, Lexington
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Norton Cancer Institute, Louisville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • University of Kentucky/Markey Cancer Center, Lexington
  • Norton Children's Hospital, Louisville
Nagre-recruitPhase 1/2
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Norton Cancer Institute, Louisville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06499285

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.